Grigoratos C Barison A Ivanov A Andreini D Amzulescu MS Mazurkiewicz L De Luca A Grzybowski J Masci PG Marczak M Heitner JF Schwitter J Gerber BL Emdin M Aquaro GD 2019 OBJECTIVES The objective of this meta-analysis was to assess the predictive value of late gadolinium enhancement (LGE) and global systolic impairment for future major adverse cardiovascular events in left ventricular noncompaction (LVNC). BACKGROUND The prognosis of patients with LVNC, with and without left ventricular dysfunction and LGE, is still unclear. METHODS A systematic review of published research and a meta-analysis reporting a combined endpoint of hard (cardiac death, sudden cardiac death, appropriate defibrillator firing, resuscitated cardiac arrest, cardiac transplantation, assist device implantation) and minor (heart failure hospitalization and thromboembolic events) events was performed. RESULTS Four studies with 574 patients with LVNC and 677 with no LVNC and an average follow-up duration of 5.2 years were analyzed. In patients with LVNC, LGE was associated with the combined endpoint (pooled odds ratio: 4.9; 95% confidence interval: 1.63 to 14.6; p = 0.005) and cardiac death (pooled odds ratio: 9.8; 95% confidence interval: 2.44 to 39.5; p < 0.001). Preserved left ventricular systolic function was found in 183 patients with LVNC: 25 with positive LGE and 158 with negative LGE. In LVNC with preserved ejection fraction, positive LGE was associated with hard cardiac events (odds ratio: 6.1; 95% confidence interval: 2.1 to 17.5; p < 0.001). No hard cardiac events were recorded in patients with LVNC, preserved ejection fraction, and negative LGE. CONCLUSIONS Patients with LVNC but without LGE have a better prognosis than those with LGE. When LGE is negative and global systolic function is preserved, no hard cardiac events are to be expected. Currently available criteria allow diagnosis of LVNC, but to further define the presence and prognostic significance of the disease, LGE and/or global systolic impairment must be considered for better risk stratification. https://sonar.ch/global/documents/278259 eng info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jcmg.2018.12.029 info:eu-repo/semantics/altIdentifier/pmid/30878415 JACC. Cardiovascular imaging. - 2019 hypertrabeculation late gadolinium enhancement left ventricular noncompaction prognosis systolic impairment Adult Contrast Media Female Fibrosis Humans Isolated Noncompaction of the Ventricular Myocardium Magnetic Resonance Imaging Male Middle Aged Myocardium Predictive Value of Tests Prognosis Risk Assessment Risk Factors Time Factors Ventricular Dysfunction, Left Ventricular Function, Left Ventricular Remodeling Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction. http://purl.org/coar/resource_type/c_6501